Dementias Completed Phase 2 Trials for Botulinum toxin type A (DB00083)

Also known as: Dementia / Dementia NOS / Amentia

IndicationStatusPhase
DBCOND0060453 (Dementias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02212119Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle StiffnessTreatment